RecruitingNot ApplicableNCT04554927

Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

Sponsor

Centre Francois Baclesse

Enrollment

438 participants

Start Date

Sep 3, 2020

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Web-application Hormono Therapy

Summary

The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria7

Patient \> 18 years old
Breast cancer patient candidate for adjuvant hormone therapy
Mastery of the French language
Patient with a cell phone and an Internet connection
Patient able to use a computer, smartphone, or tablet.
Patient affiliated to a social security system
Signing of informed consent prior to any specific study-related procedure

Exclusion Criteria8

Patient who has previously received hormone therapy for cancer.
Patient not trained in the use of the application
Any associated medical or psychiatric condition that might compromise the patient's ability to participate in the study
Patients with locoregional or metastatic recurrence
Other history of cancer.
Patient deprived of liberty, under guardianship or curatorship
Simultaneous participation in a therapeutic clinical trial or other clinical study involving a connected tool
Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons

Interventions

OTHERWEB-Application

The patients of the Web-application arm will be trained on the devices and the application will be installed either on their smartphone or on another support (computer, tablet).

OTHERStandard accompaniment

Personalized schedule of medical follow-up given to the patient